Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Should associating liver partition and portal vein ligation for staged hepatectomy be applied to hepatitis B virus-related hepatocellular carcinoma patients with cirrhosis? A multi-center study.
Lv JH, Chen WZ, Li YN, Wang JX, Fu YK, Zeng ZX, Wu JY, Wang SJ, Huang XX, Huang LM, Huang RF, Wei YG, Yan ML. Lv JH, et al. Among authors: fu yk. HPB (Oxford). 2022 Dec;24(12):2175-2184. doi: 10.1016/j.hpb.2022.10.001. Epub 2022 Oct 5. HPB (Oxford). 2022. PMID: 36280426 Free article.
Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Li SQ, Wu JY, Wu JY, Xie H, Li JH, Zeng ZX, Fu YK, Liu DY, Li H, Chen WZ, Huang JY, Yan ML. Li SQ, et al. Among authors: fu yk. J Hepatocell Carcinoma. 2023 Oct 11;10:1799-1811. doi: 10.2147/JHC.S428980. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37850080 Free PMC article.
Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY, Wu JY, Fu YK, Ou XY, Li SQ, Zhang ZB, Zhou JY, Li B, Wang SJ, Chen YF, Yan ML. Wu JY, et al. Among authors: fu yk. Ann Surg Oncol. 2024 May;31(5):3073-3083. doi: 10.1245/s10434-024-14944-3. Epub 2024 Feb 5. Ann Surg Oncol. 2024. PMID: 38316732
Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
Ou X, Wu J, Wu J, Fu Y, Zeng Z, Li S, Li Y, Liu D, Li H, Li B, Zhou J, Zhuang S, Cheng S, Zhang Z, Wang K, Qu S, Yan M. Ou X, et al. Cancer Res Treat. 2024 Oct;56(4):1207-1218. doi: 10.4143/crt.2023.1165. Epub 2024 Apr 30. Cancer Res Treat. 2024. PMID: 38697847 Free PMC article.
95 results